The results shown here not only indicate that there is a dramatic change in the expression profile of purinergic receptors in GC cells, but also suggest that purinergic signaling could be an important player in the pathophysiology of GC, reflected in the changes in proliferation of GC cells when purinergic signaling is pharmacologically manipulated. The gene discussed is P2RX7; the disease is gastric cancer.